Peijie Wu

499 total citations
19 papers, 378 citations indexed

About

Peijie Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peijie Wu has authored 19 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Peijie Wu's work include Nanoplatforms for cancer theranostics (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Peijie Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Peijie Wu collaborates with scholars based in China, Australia and Bangladesh. Peijie Wu's co-authors include Na Xie, Edouard C. Nice, Wenhui Zhang, Wei Gao, Jie Lin, Miao Su, Yanju Gong, Yu Han, Chao Liu and Han Yu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, ACS Applied Materials & Interfaces and International Journal of Molecular Sciences.

In The Last Decade

Peijie Wu

19 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peijie Wu China 8 180 106 87 78 64 19 378
Jiafeng Gao China 15 250 1.4× 79 0.7× 79 0.9× 70 0.9× 101 1.6× 22 472
Yanfang Wang China 17 174 1.0× 91 0.9× 176 2.0× 98 1.3× 50 0.8× 31 577
Jingwen Huang China 9 191 1.1× 107 1.0× 108 1.2× 53 0.7× 81 1.3× 18 427
Qie Guo China 13 209 1.2× 60 0.6× 100 1.1× 72 0.9× 77 1.2× 41 497
Yan Zong China 10 353 2.0× 82 0.8× 89 1.0× 111 1.4× 83 1.3× 30 532
Chang‐Chun Ling China 12 235 1.3× 108 1.0× 66 0.8× 61 0.8× 96 1.5× 24 530
Xinyi Luo China 12 262 1.5× 94 0.9× 63 0.7× 59 0.8× 78 1.2× 30 507
Jiayu Zhang China 14 233 1.3× 95 0.9× 122 1.4× 90 1.2× 102 1.6× 22 484
Eun Ji Lee South Korea 13 156 0.9× 76 0.7× 116 1.3× 49 0.6× 88 1.4× 31 408

Countries citing papers authored by Peijie Wu

Since Specialization
Citations

This map shows the geographic impact of Peijie Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peijie Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peijie Wu more than expected).

Fields of papers citing papers by Peijie Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peijie Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peijie Wu. The network helps show where Peijie Wu may publish in the future.

Co-authorship network of co-authors of Peijie Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Peijie Wu. A scholar is included among the top collaborators of Peijie Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peijie Wu. Peijie Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
He, Xiangning, et al.. (2025). Harnessing the interaction between redox signaling and senescence to restrain tumor drug resistance. Frontiers in Cell and Developmental Biology. 13. 1639772–1639772. 1 indexed citations
4.
Wang, Dong, et al.. (2024). Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development. International Journal of Molecular Sciences. 25(12). 6444–6444. 4 indexed citations
5.
Zhu, Sha, et al.. (2023). Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins. Pharmaceuticals. 16(8). 1114–1114. 4 indexed citations
6.
Wu, Peijie, Yueqiang Wen, Chao Liu, et al.. (2023). The zhuyu pill relieves rat cholestasis by regulating the mRNA expression of lipid and bile metabolism associated genes. Frontiers in Pharmacology. 14. 1280864–1280864. 4 indexed citations
7.
Sun, Xin, et al.. (2023). TMT-based proteomics analysis identifies the interventional mechanisms of Qijia Rougan decoction in improving hepatic fibrosis. Journal of Ethnopharmacology. 319(Pt 3). 117334–117334. 7 indexed citations
8.
Wu, Peijie, Wenjun Wu, Jun Han, et al.. (2023). Therapeutic potential and pharmacological significance of extracellular vesicles derived from traditional medicinal plants. Frontiers in Pharmacology. 14. 1272241–1272241. 22 indexed citations
9.
Ming, Hui, Bowen Li, Hailong Tian, et al.. (2022). A minimalist and robust chemo-photothermal nanoplatform capable of augmenting autophagy-modulated immune response against breast cancer. Materials Today Bio. 15. 100289–100289. 29 indexed citations
10.
Liu, Chao, Renwei Huang, Yu Han, et al.. (2022). Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks. Phytomedicine. 103. 154226–154226. 8 indexed citations
11.
Li, Lei, Hailong Tian, Zhe Zhang, et al.. (2022). Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer. ACS Applied Materials & Interfaces. 15(1). 452–468. 53 indexed citations
12.
Wu, Peijie, et al.. (2022). Identification of Six Genes as Diagnostic Markers for Colorectal Cancer Detection by Integrating Multiple Expression Profiles. Journal of Oncology. 2022. 1–17. 1 indexed citations
14.
Wu, Peijie, Wei Gao, Miao Su, et al.. (2021). Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Frontiers in Cell and Developmental Biology. 9. 641469–641469. 147 indexed citations
15.
Li, Xia, Han Yu, Yanju Gong, et al.. (2021). Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms. Journal of Ethnopharmacology. 284. 114801–114801. 16 indexed citations
16.
Wu, Peijie, Ling Qiao, Han Yu, et al.. (2021). Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation. Frontiers in Cell and Developmental Biology. 9. 758632–758632. 15 indexed citations
17.
Liu, Chao, Han Yu, Xia Li, et al.. (2021). Anti-hepatocellular carcinoma efficacy of Fuzheng Xiaozheng prescription and its interventional mechanism studies. Journal of Ethnopharmacology. 285. 114913–114913. 7 indexed citations
18.
Zhao, Hongmei, et al.. (2019). The Shigella type three secretion system effector OspF invades host nucleus by binding host importin α1. World Journal of Microbiology and Biotechnology. 35(5). 71–71. 5 indexed citations
19.
Wu, Peijie, et al.. (2018). High-throughput, one-step screening, cloning and expression based on the lethality of DpnI in Escherichia coli. Biochemical and Biophysical Research Communications. 504(1). 177–183. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026